<DOC>
	<DOCNO>NCT01122953</DOCNO>
	<brief_summary>To investigate bioequivalence two compound ( phenytoin epamin ) randomize , single dose study fast condition healthy volunteer .</brief_summary>
	<brief_title>Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer , Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting Conditions</brief_title>
	<detailed_description>Bioequivalence study healthy volunteer</detailed_description>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year Body Mass Index ( BMI ) 18 26.9 kg/m2 ± 10 % variation ideal weight ; total body weight &gt; 50 kg ( 110 lb ) . An informed consent document sign date subject legally acceptable representative . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>EPAMIN</keyword>
	<keyword>PHENYTOIN</keyword>
</DOC>